Potential therapeutic and pharmacological strategies for SARS-CoV2

BACKGROUND: At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pharm Investig
Auteurs principaux: Ghareeb, Doaa A., Saleh, Samar R., Nofal, Mohammed S., Kaddah, Mohamed M. Y., Hassan, Salma. F., Seif, Inas K., El-Zahaby, Sally A., Khedr, Shaimaa M., Kenawy, Marwa Y., Masoud, Aliaa A., Soudi, Salma A., Sobhy, Ahmed A., Sery, Jaillan G., El-Wahab, Miral G. Abd, Elmoneam, Alshimaa A. Abd, Al-mahallawi, Abdulaziz Mohsen, El-Demellawy, Maha A.
Format: Artigo
Langue:Inglês
Publié: Springer Singapore 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933375/
https://ncbi.nlm.nih.gov/pubmed/33688448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40005-021-00520-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires